Our predication was that the NO-dependent H2S cardioprotective action of sulfide salts would be attenuated in obese mice, since these animals exhibit endothelial dysfunction, reduced eNOS activity/function and lower NO levels (Lundberg and Weitzberg 2022). The gene discussed is NOS3; the disease is endothelial dysfunction.